![]() |
|||||||||||||||
|
Conference/ProceedingsNCIC CTG Publications [home] Miller KD, Wang M, Gralow J, Dickler M, Cobleigh MA, Perez EA, Shenkier TN, Davidson NE. E2100: a randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer. 2005. Proc Am Soc Clin Oncol. Scientific Symposium: Advances in Monoclonal Antibody Therapy for Breast Cancer. Piccart-Gebhart MJ. First results of the HERA trial. 2005. Am.Soc.Clin.Oncol. Scientific Symposium: Advances in Monoclonal Antibody Therapy for Breast Cancer. Piccart-Gebhart MJ. First results of the HERA trial (slide presentation). 2005, Proc Am Soc Clin Oncol. Scientific Session: Advances in Monoclonal Antibody Therapy for Breast Cancer Tu D. Rao's score tests in survival analysis: examples and Bartlett type adjustments (invited presentation). Reflections on the past and visions for the future: an international conference in honor of Professor C.R. Rao, 2000. Paul N. Recent trends of data management of cancer clinical trials in Canada. Proceedings of the EORTC Study Group on Data Management, 1991. Paul N. Coping strategies of NCIC CTG data managers. Proceedings of the EORTC Study Group on Data Management, 1991. |
||||
|
||||